Practices |

Business Litigation

Protecting Your
Business Interests

The seasoned members of our Business Litigation Group advise and represent startups, mid-stage and mature businesses, private equity funds, officers, directors, executives, and other individuals in a wide range of complex business disputes across multiple industries. Our clients come from a diverse range of industries and business sectors, including Private Equity, Venture Capital, Life Sciences, Financial Services, HealthCare, Manufacturing & Industrial Services, and Technology.

Did You Know?
2004

MBBP has had a presence at CIC-Cambridge from its earliest days - 2004 to be exact.

Matters handled by our Business Litigation Group include complex commercial litigation involving breaches of contract, unfair trade practices, breaches of fiduciary duty, fraud, misrepresentation, theft of trade secrets, licensing violations, ongoing corporate and partnership management or operational disputes, and dissolution issues.

We also regularly handle disputes arising out of mergers and acquisitions involving public and private companies, including defending against plaintiff strike suits seeking to enjoin a sale and post-closing indemnity claims or breach of warranty claims, and are highly experienced in handling individual actions, derivative actions, and class actions.

Cross-Border Capabilities

Our litigators are experienced in the representation of foreign and international clients in U.S.-based state and federal court litigation having represented clients from Germany, China, Italy, and Australia in such disputes.  Our litigators also team with an international group of law firms with offices in countries that cover 80% of the world’s GDP so that they can seamlessly provide litigation services to our domestic clients who find themselves involved in litigation or adversarial proceedings in other countries.

Representative Matters:

  • Health care provider in breach of contract actions.
  • Private equity fund in dispute over management and control of portfolio company.
  • Seller in post-closing indemnity claims brought by a Fortune 200 company.
  • Buyer in post-closing indemnity claims concerning breaches of representations and earn out issues.
  • Private equity funds in SEC investigations.
  • Seller and board of directors in five class actions challenging sale of public company in the seismic exploration space.
  • Seller and board of directors in five class actions challenging sale of public company in the health care space.